Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma.
Jessica E PritchardLauren E WilsonSamuel M MillerMelissa A GreinerHarvey Jay CohenDeborah R KayeTian ZhangMichaela A DinanPublished in: Journal of the American Geriatrics Society (2022)
Patients with preexisting MCI/D were half as likely to start an OAA during the year following mRCC diagnosis than patients without comorbid MCI/D. The 90-day adherence of OAA initiators was not significantly different between those with and without preexisting MCI/D. In light of this, clinicians should assess mRCC patients for cognitive impairment and take steps to optimize OAA utilization by those with MCI/D.